ptake and excresion of terbutalin in healthy trained males
Phase 1
- Conditions
- Pharmacological properties of terbutalin regarding uptake and excretionMedDRA version: 18.0Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Body processes [G] - Physiological processes [G07]
- Registration Number
- EUCTR2014-002140-40-DK
- Lead Sponsor
- Bispebjerg University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Male between 18-40
Physically active at least 5 hours a week
Non smoker
No daily use of medicine
VO2 max at least 60,0 ml/kg/min
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 12
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Hypersensitivity towards the active substance or any one of the other substances within the medicine
Coronary heart diease, asthma or other cronical disease
Not able to get doctors permission to participate in the trials after an objective test
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method